Washington, D.C. – This week, U.S. Sen. Shelley Moore Capito, R-W.Va., joined 13 of her Senate colleagues in urging the Federal Trade Commission (FTC) to complete its investigation into the health care industry’s powerful prescription drug middlemen: pharmacy benefit managers (PBMs).
This bipartisan effort, led by U.S. Senators Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., includes requesting a status update on the investigation, which has been open for over 18 months.
“We support the...
Read More